Derived from Human Embryonic Stem Cells Researchers Transplant Functional Dopaminergic Neurons (VIDEO)


Parkinson’s disease is a progressive neurodegenerative disorder marked by the loss of dopamine-producing neurons in the brain. Since dopamine is involved in the regulation of movement and emotional affect, the loss of these neurons leads to deficits in motor activity and emotional response. Cellular therapies that aim to restore lost dopaminergic neurons hold promise for slowing the progression of Parkinson’s.

Prof. Parmar and colleagues showed that following transplantation, the embryonic stem cell-derived dopaminergic neurons exhibited the functional characteristics of native dopaminergic neurons, including dopamine production as well as long distance extension and connection with target regions in the brain.

Unlike fetal stem cells, which have been previously used to create dopaminergic neurons, embryonic stem cells (from existing stem cell lines) offer an abundant, readily accessible supply of cells. Overall, the results of this study demonstrate an important pre-clinical proof of concept, with an estimated time to human trials set for approximately 3 years.

Source by : Med Gadget

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s